SECHI, Leonardo Alberto
 Distribuzione geografica
Continente #
NA - Nord America 21.499
EU - Europa 6.571
AS - Asia 1.356
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 8
OC - Oceania 6
Totale 29.490
Nazione #
US - Stati Uniti d'America 21.339
UA - Ucraina 2.591
IT - Italia 1.098
DE - Germania 970
CN - Cina 937
FI - Finlandia 824
IE - Irlanda 435
SE - Svezia 325
TR - Turchia 251
CA - Canada 156
GB - Regno Unito 105
VN - Vietnam 67
BE - Belgio 57
RU - Federazione Russa 44
FR - Francia 40
IR - Iran 31
IN - India 27
EU - Europa 24
TG - Togo 23
NL - Olanda 18
KR - Corea 15
AT - Austria 12
ES - Italia 12
AU - Australia 6
JP - Giappone 6
TW - Taiwan 6
CH - Svizzera 4
CL - Cile 4
EE - Estonia 4
PL - Polonia 4
RO - Romania 4
RS - Serbia 4
IL - Israele 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BT - Bhutan 2
CZ - Repubblica Ceca 2
HR - Croazia 2
ME - Montenegro 2
MX - Messico 2
PE - Perù 2
PT - Portogallo 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 29.490
Città #
Woodbridge 2.604
Fairfield 2.543
Jacksonville 1.859
Ann Arbor 1.741
Chandler 1.482
Houston 1.474
Ashburn 1.223
Wilmington 1.106
Dearborn 1.061
Seattle 980
Cambridge 886
Princeton 469
Dublin 431
Beijing 409
Izmir 247
Udine 187
San Diego 181
Ottawa 138
Des Moines 112
Ogden 101
Norwalk 91
Hefei 87
Nanjing 76
Boardman 72
Milan 70
Kunming 69
San Mateo 68
Dong Ket 66
Falls Church 59
Brussels 48
Redmond 48
Rome 40
Trieste 35
Guangzhou 34
Grafing 31
Helsinki 30
New York 30
Jinan 24
Lomé 23
Washington 22
Nanchang 21
Leawood 18
Indiana 16
Fuzhou 15
Hebei 14
Saint Petersburg 14
Zanjan 14
Mcallen 13
Andover 12
Los Angeles 12
Wuhan 12
Pignone 11
Toronto 11
Baotou 10
Codroipo 10
Hangzhou 10
Phoenix 10
Vienna 10
Henderson 9
Nanning 9
Tavagnacco 9
Xian 9
Augusta 8
Bologna 8
Chongqing 8
Shenyang 8
Simi Valley 8
Venezia 8
Vicenza 8
Bitetto 7
Shanghai 7
Taranto 7
Torre Del Greco 7
Turin 7
Zhengzhou 7
Cantu 6
Changsha 6
Chengdu 6
Mumbai 6
Palermo 6
Paris 6
Taipei 6
Wenzhou 6
Castellammare Di Stabia 5
Gorizia 5
Harbin 5
Pescara 5
Porcia 5
Pune 5
Sacramento 5
Shaoxing 5
Taizhou 5
Tappahannock 5
Venice 5
Ardabil 4
Bari 4
Belgrade 4
Catania 4
Eindhoven 4
Madrid 4
Totale 20.751
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 237
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 152
Primary aldosteronism: cardiovascular, renal and metabolic implications 150
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 141
Aldosterone and the heart: from basic research to clinical evidence 141
Methacrylates allergy in a professional beautician 137
Aldosterone and Left Ventricular Remodeling 135
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 133
Abnormalities of insulin receptors in spontaneously hypertensive rats 130
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 130
BLUNTED EFFECT OF ANP ON HEMATOCRIT AND PLASMA-VOLUME IN STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS IN RATS 130
Venous thrombosis and acute renal failure in paroxysmal nocturnal haemoglobinuria. 129
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 126
SERUM-INSULIN, INSULIN SENSITIVITY, AND ERYTHROCYTE SODIUM-METABOLISM IN NORMOTENSIVE AND ESSENTIAL HYPERTENSIVE SUBJECTS WITH AND WITHOUT OVERWEIGHT 125
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 124
Aldosterone and the heart: still an unresolved issue? 121
Aldosterone, Organ Damage, and Dietary Salt 120
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 120
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 119
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 119
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 119
Nickel and sulfites food allergy in patients with angioedema associated with ACE inhibitor use 117
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 115
Intrahepatic cholestatis of pregnancy; a in vivo model of the hepatic clearance of adiponectin 115
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 115
The emergent cardiovascular risk factors and organ damage in arterial hypertension 114
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 114
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 114
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 114
Prohypertensive effect of insulin: possible role of the sympathetic system 113
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 113
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II) 113
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 113
Treatment of primary aldosteronism and organ protection 113
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 112
Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers 112
Benzodiazepines: an old class of new antihypertensive drugs? 112
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 111
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 111
Abnormalities of glucose metabolism in patients with early renal failure 110
Kidney in primary aldosteronism: a key determinant of treatment outcome 110
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 110
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes 110
Spontaneous restoration of sinus rhythm after cardiac surgery 109
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 109
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 109
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 108
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS-C INFECTION WITH NO EVIDENCE OF LIVER-DISEASE 107
Benign familial macrocytosis 107
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 107
Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat 106
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 106
Salt, hypertension, and cardiovascular disease 106
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 106
Cardiovascular outcomes in patients with primary aldosteronism after treatment 106
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 105
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 105
DISTRIBUTION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN RAT AND HUMAN KIDNEY 104
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 104
ANTIHYPERTENSIVE EFFECT OF INSULIN REDUCTION IN DIABETIC-HYPERTENSIVE PATIENTS 103
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial 103
Elevated serum CA 19-9 in hepatic actinomycosis 103
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 103
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 102
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 102
Renal function in primary aldosteronism 101
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 101
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 101
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects 100
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 100
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 100
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 100
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 99
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 99
THE CARDIAC RENIN-ANGIOTENSIN SYSTEM IN STZ-INDUCED DIABETES 98
CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT-KIDNEY AND HEART USING THE NONPEPTIDE ANTAGONISTS DUP-753 AND PD-123-177 98
Potassium-sparing diuretics in hypertension 98
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 98
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 98
The SPARTACUS Trial: Controversies and Unresolved Issues 98
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 98
URODILATIN BINDS TO AND ACTIVATES RENAL RECEPTORS FOR ATRIAL-NATRIURETIC-PEPTIDE 97
Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus 97
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 97
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 96
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 96
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 96
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 96
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 95
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. 95
Correlazioni clinico-prognostiche del diabete mellito in pazienti con arteriopatia degli arti inferiori sintomatica:dati preliminari 94
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 94
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 93
INSULINEMIA AND BLOOD-PRESSURE - RELATIONSHIPS IN PATIENTS WITH PRIMARY AND SECONDARY HYPERTENSION, AND WITH OR WITHOUT GLUCOSE-METABOLISM IMPAIRMENT 92
EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS 92
Glucose metabolism in early renal failure 92
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 92
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 92
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 91
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 91
Totale 11.014
Categoria #
all - tutte 96.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.711 0 0 0 0 0 0 0 0 0 0 1.065 646
2019/20208.373 403 403 256 1.139 579 1.527 963 1.032 543 706 178 644
2020/20215.176 147 556 166 674 162 681 240 604 892 182 624 248
2021/20223.594 136 421 153 263 100 149 201 212 55 585 692 627
2022/20233.748 539 211 75 421 328 1.103 14 238 520 76 112 111
2023/20241.087 185 92 94 56 234 129 38 32 152 67 8 0
Totale 30.503